Not applicableActive Not RecruitingNCT04447651
What this trial is testing
Patient Response to Immunotherapy Using Spliceosome Mutational Markers (PRISMM)
Who this might be right for
Metastatic Solid TumorSF3B1 Gene MutationSpliceosome Mutation+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 6